Skip to main content

Tekla Capital Management LLC

SEC CIK
0001300336
Latest filing
Aug 10, 2023

HZNP holding history

Horizon Therapeutics Public Ltd Co in every 13F filed by Tekla Capital Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HZNP overviewAll 13F holders of HZNPFull Q2 2023 holdings

Shares (Q2 2023)
72,425
Value
$7.45M
% of portfolio
0.3%
Quarters held
9
Since Q1 2021
Holdings of HZNP by Tekla Capital Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202372,425$7.45M0.3%+72,425NewHolders
Q1 20230$00.0%−415,053−100.0%Sold outHolders
Q4 2022415,053$47.2M1.8%−319,300−43.5%ReducedHolders
Q3 2022734,353$45.4M1.9%−141,736−16.2%ReducedHolders
Q2 2022876,089$69.9M2.7%−83,350−8.7%ReducedHolders
Q1 2022959,439$100.9M3.5%+61,899+6.9%AddedHolders
Q4 2021897,540$96.7M3.1%−12,800−1.4%ReducedHolders
Q3 2021910,340$99.7M3.2%−26,000−2.8%ReducedHolders
Q2 2021936,340$87.7M2.8%+125,408+15.5%AddedHolders
Q1 2021810,932$74.6M2.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.